Red ginseng marc oil inhibits iNOS and COX-2 via NFκB and p38 pathways in LPS-stimulated RAW 264.7 macrophages

Molecules

Volumn 17, Issue 12, 2012, Pages 13769-13786

  Bak, Min Ji ^a   Hong, Soon Gi ^b   Lee, Jong Won ^b   Jeong, Woo Sik ^a  

^a Inje University   (South Korea)

^b Korea Ginseng Corporation   (South Korea)

Author keywords

Anti inflammation; Chemoprevention; COX 2; INOS; MAPK; MKK3 6; NFB; P38; Red ginseng marc oil; TAK1

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE OIL;

ANIMAL; ARTICLE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM; MOUSE; PANAX; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PANAX; PHOSPHORYLATION; PLANT OILS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871541582     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171213769     Document Type: Article

References (57)

1. Chung, H.Y.; Cesari, M.; Anton, S.; Marzetti, E.; Giovannini, S.; Seo, A.Y.; Carter, C.; Yu, B.P.; Leeuwenburgh, C. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8, 18-30.
2. Chen, S.R.; Xu, X.Z.; Wang, Y.H.; Chen, J.W.; Xu, S.W.; Gu, L.Q.; Liu, P.Q. Icariin derivative inhibits inflammation through suppression of p38 mitogen-Activated protein kinase and nuclear factor-kappaB pathways. Biol. Pharm. Bull. 2011, 33, 1307-1313.
3. Uto, T.; Suangkaew, N.; Morinaga, O.; Kariyazono, H.; Oiso, S.; Shoyama, Y. Eriobotryae folium extract suppresses LPS-induced iNOS and COX-2 expression by inhibition of NF-kappaB and MAPK activation in murine macrophages. Am. J. Chin. Med. 2011, 38, 985-994.
4. Sethi, G.; Sung, B.; Aggarwal, B.B. Nuclear factor-kappaB activation: From bench to bedside. Exp. Biol. Med. (Maywood) 2008, 233, 21-31.
5. Guha, M.; Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13, 85-94.
6. Yamazaki, Y.; Kawano, Y. Inhibitory effects of herbal alkaloids on the tumor necrosis factor-Alpha and nitric oxide production in lipopolysaccharide- stimulated RAW264 macrophages. Chem. Pharm. Bull. (Tokyo) 2011, 59, 388-391.
7. Lin, C.M.; Huang, S.T.; Liang, Y.C.; Lin, M.S.; Shih, C.M.; Chang, Y.C.; Chen, T.Y.; Chen, C.T. Isovitexin suppresses lipopolysaccharide-mediated inducible nitric oxide synthase through inhibition of NF-kappa B in mouse macrophages. Planta Med. 2005, 71, 748-753.
8. Shishodia, S.; Potdar, P.; Gairola, C.G.; Aggarwal, B.B. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: Correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003, 24, 1269-1279.
9. Song, S.H.; Min, H.Y.; Han, A.R.; Nam, J.W.; Seo, E.K.; Park, S.W.; Lee, S.H.; Lee, S.K. Suppression of inducible nitric oxide synthase by (-)-isoeleutherin from the bulbs of Eleutherine americana through the regulation of NF-kappaB activity. Int. Immunopharmacol. 2009, 9, 298-302.
10. Saklatvala, J. Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr. Drug Targets 2007, 8, 305-313.
11. Vanden Berghe, W.; Plaisance, S.; Boone, E.; de Bosscher, K.; Schmitz, M.L.; Fiers, W.; Haegeman, G. p38 and extracellular signal-regulated kinase mitogen-Activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 1998, 273, 3285-3290.
12. Kyriakis, J.M.; Avruch, J. Mammalian mitogen-Activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81, 807-869.
13. Yoon, W.J.; Moon, J.Y.; Song, G.; Lee, Y.K.; Han, M.S.; Lee, J.S.; Ihm, B.S.; Lee, W.J.; Lee, N.H.; Hyun, C.G. Artemisia fukudo essential oil attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Food Chem. Toxicol. 2010, 48, 1222-1229.
14. Kim, J.Y.; Shin, J.S.; Ryu, J.H.; Kim, S.Y.; Cho, Y.W.; Choi, J.H.; Lee, K.T. Anti-inflammatory effect of anemarsaponin B isolated from the rhizomes of Anemarrhena asphodeloides in LPS-induced RAW 264.7 macrophages is mediated by negative regulation of the nuclear factor-kappaB and p38 pathways. Food Chem. Toxicol. 2009, 47, 1610-1617.
15. Kim, Y.J.; Kim, H.C.; Ko, H.; Amor, E.C.; Lee, J.W.; Yang, H.O. Stercurensin inhibits nuclear factor-kappaB-dependent inflammatory signals through attenuation of TAK1-TAB1 complex formation. J. Cell. Biochem. 2011, 112, 548-558.
16. Jang, D.J.; Lee, M.S.; Shin, B.C.; Lee, Y.C.; Ernst, E. Red ginseng for treating erectile dysfunction: A systematic review. Br. J. Clin. Pharmacol. 2008, 66, 444-450.
17. Kim, J.Y.; Kim, J.J.; Kim, H.J. Effect of Oral Administration of Korean Red Ginseng on Influenza A (H1N1) Virus Infection J. Ginseng Res. 2011, 35, 104-110.
18. Park, B.J.; Lim, Y.S.; Lee, H.J.; Eum, W.S.; Park, J.; Han, K.H.; Choi, S.Y.; Lee, K.S. Anti-oxidative effects of Phellinus linteus and red ginseng extracts on oxidative stress-induced DNA damage. BMB Rep. 2009, 42, 500-505.
19. Hwang, J.T.; Lee, M.S.; Kim, H.J.; Sung, M.J.; Kim, H.Y.; Kim, M.S.; Kwon, D.Y. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother. Res. 2009, 23, 262-266.
20. Seo, E.Y.; Kim, W.K. Red Ginseng Extract Reduced Metastasis of Colon Cancer Cells In Vitro and In Vivo. J. Ginseng Res. 2011, 35, 315-324.
21. Abdel-Aziem, S.H.; Mosaad, A.; Gamil, K.; El-Kady, A.A.; El-Nekeety, A.A.; Nam, K.W. Therapeutic Effects of Korean Red Ginseng Extract in Egyptian Patients with Chronic Liver Diseases. J. Ginseng Res. 2011, 35, 69-79.
22. Alexopoulos, A.; Kimbaris, A.C.; Plessas, S.; Mantzourani, I.; Theodoridou, I.; Stavropoulou, E.; Polissiou, M.G.; Bezirtzoglou, E. Antibacterial activities of essential oils from eight Greek aromatic plants against clinical isolates of Staphylococcus aureus. Anaerobe 2011, 17, 399-402.
23. Waikedre, J.; Vitturo, C.I.; Molina, A.; Theodoro, P.N.; do Rosario Rodrigues Silva, M.; Espindola, L.S.; Maciuk, A.; Fournet, A. Antifungal Activity of the Essential Oils of Callitris neocaledonica and C. sulcata Heartwood (Cupressaceae). Chem. Biodivers. 2012, 9, 644-653.
24. Kim, H.J.; Kang, H.J.; Seo, J.Y.; Lee, C.H.; Kim, Y.S.; Kim, J.S. Antiobesity effect of oil extract of ginseng. J. Med. Food 2011, 14, 573-583.
25. Sindhu, S.; Chempakam, B.; Leela, N.K.; Suseela Bhai, R. Chemoprevention by essential oil of turmeric leaves (Curcuma longa L.) on the growth of Aspergillus flavus and aflatoxin production. Food Chem. Toxicol. 2011, 49, 1188-1192.
26. Yoon, W.J.; Moon, J.Y.; Kang, J.Y.; Kim, G.O.; Lee, N.H.; Hyun, C.G. Neolitsea sericea essential oil attenuates LPS-induced inflammation in RAW 264.7 macrophages by suppressing NF-kappaB and MAPK activation. Nat. Prod. Commun. 2010, 5, 1311-1316.
27. Bak, M.J.; Jun, M.; Jeong, W.S. Antioxidant and Hepatoprotective Effects of the Red Ginseng Essential Oil in H(2)O(2)-Treated HepG2 Cells and CCl(4)-Treated Mice. Int. J. Mol. Sci. 2011, 13, 2314-2330.
28. Surh, Y.J.; Chun, K.S.; Cha, H.H.; Han, S.S.; Keum, Y.S.; Park, K.K.; Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001, 480-481, 243-268.
29. Pan, M.H.; Lai, C.S.; Dushenkov, S.; Ho, C.T. Modulation of inflammatory genes by natural dietary bioactive compounds. J. Agric. Food Chem. 2009, 57, 4467-4477.
30. Aggarwal, B.B.; Shishodia, S.; Sandur, S.K.; Pandey, M.K.; Sethi, G. Inflammation and cancer: How hot is the link Biochem. Pharmacol. 2006, 72, 1605-1621.
31. Korhonen, R.; Lahti, A.; Kankaanranta, H.; Moilanen, E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 2005, 4, 471-479.
32. Feldmann, M. Many cytokines are very useful therapeutic targets in disease. J. Clin. Invest. 2008, 118, 3533-3536.
33. Ren, K.; Torres, R. Role of interleukin-1beta during pain and inflammation. Brain Res. Rev. 2009, 60, 57-64.
34. Sugita, T. Targeting therapy for inflammatory diseases by anti-TNFalpha biologics. Yakugaku Zasshi 2009, 129, 19-24.
35. Ding, C.; Cicuttini, F.; Li, J.; Jones, G. Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opin. Investig. Drugs 2009, 18, 1457-1466.
36. Medzhitov, R.; Horng, T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9, 692-703.
37. Ghosh, S.; Hayden, M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 2008, 8, 837-848.
38. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511.
39. Hsieh, I.N.; Chang, A.S.; Teng, C.M.; Chen, C.C.; Yang, C.R. Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-kappaB and JNK/p38 MAPK activation pathways. J. Biomed. Sci. 2011, 18, 28.
40. Baeuerle, P.A.; Henkel, T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12, 141-179.
41. Dev, A.; Iyer, S.; Razani, B.; Cheng, G. NF-kappaB and innate immunity. Curr. Top. Microbiol. Immunol. 2011, 349, 115-143.
42. Jeong, W.S.; Kim, I.W.; Hu, R.; Kong, A.N. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm. Res. 2004, 21, 661-670.
43. Kim, C.S.; Kawada, T.; Kim, B.S.; Han, I.S.; Choe, S.Y.; Kurata, T.; Yu, R. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-A degradation in LPS-stimulated peritoneal macrophages. Cell. Signal. 2003, 15, 299-306.
44. Yadav, P.N.; Liu, Z.; Rafi, M.M. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-Activated protein kinase, p44/42, and transcription factor nuclear factor-kappa B. J. Pharmacol. Exp. Ther. 2003, 305, 925-931.
45. Bak, M.J.; Jeong, J.H.; Kang, H.S.; Jin, K.S.; Ok, S.; Jeong, W.S. Cedrela sinensis leaves suppress oxidative stress and expressions of iNOS and COX-2 via MAPK signaling pathways in RAW 264.7 cells. J. Food Sci. Nutr. 2009, 14, 269-276.
46. Costa, G.; Francisco, V.; Lopes, M.C.; Cruz, M.T.; Batista, M.T. Intracellular signaling pathways modulated by phenolic compounds: Application for new anti-inflammatory drugs discovery. Curr. Med. Chem. 2012, 19, 2876-2900.
47. Johnson, G.L.; Lapadat, R. Mitogen-Activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1912.
48. Rajapakse, N.; Kim, M.M.; Mendis, E.; Kim, S.K. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-Activated protein kinase-mediated nuclear factor-kappaB signaling. Immunology 2008, 123, 348-357.
49. Kaminska, B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy- From molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 2005, 1754, 253-262.
50. Pearson, G.; Robinson, F.; Beers Gibson, T.; Xu, B.E.; Karandikar, M.; Berman, K.; Cobb, M.H. Mitogen-Activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 2001, 22, 153-183.
51. Raingeaud, J.; Whitmarsh, A.J.; Barrett, T.; Derijard, B.; Davis, R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-Activated protein kinase signal transduction pathway. Mol. Cell. Biol. 1996, 16, 1247-1255.
52. Cho, S.Y.; Park, S.J.; Kwon, M.J.; Jeong, T.S.; Bok, S.H.; Choi, W.Y.; Jeong, W.I.; Ryu, S.Y.; Do, S.H.; Lee, C.S.; et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol. Cell. Biochem. 2003, 243, 153-160.
53. Lo, A.H.; Liang, Y.C.; Lin-Shiau, S.Y.; Ho, C.T.; Lin, J.K. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 2002, 23, 983-991.
54. Jeong, W.S.; Lachance, P.A. Phytosterols and Fatty Acids in Fig (Ficus carica, var. Mission) Fruit and Tree Components. J. Food Sci. 2001, 66, 278-281.
55. Othman, R.A.; Moghadasian, M.H. Beyond cholesterol-lowering effects of plant sterols: Clinical and experimental evidence of anti-inflammatory properties. Nutr. Rev. 2011, 69, 371-382.
56. Zhao, Y.Q.; Yuan, C.L. Chemical constituents of the fruit of Panax ginseng C. A. Meyer. Zhongguo Zhong Yao Za Zhi 1993, 18, 296-297, 319.
57. Beveridge, T.H.; Li, T.S.; Drover, J.C. Phytosterol content in American ginseng seed oil. J. Agric. Food Chem. 2002, 50, 744-750.